Phase 1/2, Randomized, Controlled Assessment of the Safety Of Gintuit Versus Bio-Gide in Subjects Requiring Socket Grafting
Phase of Trial: Phase I/II
Latest Information Update: 28 Sep 2015
Price : $35 *
At a glance
- Drugs Allogeneic cultured keratinocytes and fibroblasts (Primary) ; Collagen (Primary)
- Indications Postoperative complications; Tooth disorders
- Focus Adverse reactions
- Sponsors Organogenesis
- 23 Sep 2015 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov record.
- 22 Feb 2015 Planned End Date changed from 1 Oct 2014 to 1 May 2015 as reported by ClinicalTrials.gov record.
- 22 Feb 2015 Planned primary completion date changed from 1 Oct 2014 to 1 May 2015 as reported by ClinicalTrials.gov record.